...
首页> 外文期刊>Journal of Cancer Research and Therapeutics >Treatment outcomes of malignant fibrous histiocytoma of the maxillary sinus
【24h】

Treatment outcomes of malignant fibrous histiocytoma of the maxillary sinus

机译:上颌窦恶性纤维组织细胞瘤的治疗结果

获取原文
           

摘要

Background: Malignant fibrous histiocytoma (MFH) is an uncommon neoplasm of maxillary sinus. This study was designed to investigate the clinical courses and summarize the experience of the treatment outcomes. Materials and Methods: This is a retrospective analysis which included patients with MFH of the maxillary sinus from January 1980 to December 2008 treated in our institute. Survival data were analyzed by means of the Kaplan–Meier method using univariate analysis and Cox regression model using multivariate analysis. Results: The study included 31 patients. Of which, one patient received radical radiotherapy, and thirty patients received surgical resection. Of these, thirty patients received preoperative radiotherapy, and 11 patients received postoperative radiotherapy. Radical resection with clear surgical margins was obtained in twelve patients (80%) after preoperative radiotherapy, and in eight patients (53.3%) with postoperative radiotherapy (P = 0.221). The 3-year overall survival rate (OS) and recurrence-free survival rate (RFS) were 59.0% and 43.5%, respectively. Patients treated with a radical resection had significantly better survival than patients with a nonradical resection. Three-year OS was 79.8% and 28.1%, 3-year RFS was 61.9% and 18.5%, respectively (P = 0.001 and 0.029, respectively). Local recurrence rate (LRR) was lower in patients resected with clear surgical margins than patients with unclear or uncertain margins, and the 3 years LRR was 33.3% and 72.2%, respectively (P = 0.052). Conclusions: Surgical resection is the mainstay of treatment for MFH of the maxillary sinus. A radical resection with clear margins is essential for excellent local control and long-term survival.
机译:背景:恶性纤维组织细胞瘤(MFH)是上颌窦的罕见肿瘤。本研究旨在调查临床过程并总结治疗结果的经验。材料与方法:这是一项回顾性分析,其中包括我院1980年1月至2008年12月治疗的上颌窦MFH患者。生存数据通过Kaplan–Meier方法进行单变量分析,并通过Cox回归模型进行多变量分析。结果:该研究包括31例患者。其中一名患者接受了根治性放疗,三十名患者接受了手术切除。其中,有30例接受了术前放疗,有11例接受了术后放疗。术前放疗后的十二名患者(80%)和术后放疗后的八名患者(53.3%)进行了根治性切除,具有明确的手术切缘(P = 0.221)。 3年总生存率(OS)和无复发生存率(RFS)分别为59.0%和43.5%。接受根治性切除术的患者的生存率明显高于非根治性切除术的患者。三年OS分别为79.8%和28.1%,三年RFS分别为61.9%和18.5%(P分别为0.001和0.029)。切缘清楚的患者的局部复发率(LRR)低于切缘不确定或不确定的患者,其三年复发率分别为33.3%和72.2%(P = 0.052)。结论:手术切除是上颌窦MFH治疗的主要手段。切缘清晰的根治性切除术对于出色的局部控制和长期生存至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号